Australia, Jan. 8 -- AstraZeneca Ireland Ltd., owns the trademark (2492278) for 'BAXTYMA' till Oct. 22, 2034.
Status: registered:
Registered/protected
Class: 5 [Pharmaceutical preparations and substances.]
Type of Mark: Word
Date of Acceptance: Oct. 23, 2024
Registration Advertised: Jan. 7
For further details contact Dennemeyer & Associates.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2492278.
Disclaimer: Curated by HT Syndication.
